Phase I – Other

1,064 trials 249 recruiting

Filter these 1,064 trials by condition, country, sponsor and more.

Open in Search →

A research study to look at the distribution and effects of coramitug on amyloid deposits in heart tissue using PET/CT imaging in people wit… Recruiting

2024-519372-22-00 transthyretin amyloid amyloidosis cardiomyopathy (ATTR 2026-02-12
Study of exposure to substances prohibited by the World Anti-Doping Agency in healthy volunteers (ESPAMA_4). Proof of concept Recruiting

2025-521814-25-01 Healthy volunteers 2026-02-11
A Study of JNJ-90301900 in Combination with Concurrent Chemoradiation Therapy in LA HNSCC Recruiting

2025-522914-22-00 Locally Advanced Head and Neck Squamous Cell Carcinoma 2026-02-11
A Study Evaluating the Safety and Tolerability of a Novel Formulation of QRL-101 in Healthy Participants Recruiting

2025-524310-28-00 Epilepsy, amotrophic lateral sclerosis, neuropathy 2026-02-02
Long-Term Follow-up of AvenCell-Sponsored CAR-T Cell Clinical Trials Recruiting

2025-521717-67-00 Acute myeloid leukemia 2026-01-29
A study to investigate the effect of capivasertib on the pharmacokinetics of oral dextromethorphan (CYP2D6) in healthy participants Recruiting

2025-523995-21-00 Healthy participants 2026-01-27
INTERACT-FAPI Recruiting

2024-520037-76-00 Peritoneal metastases 2026-01-27
A trial to learn how safe AZD5335 is and if a drug called itraconazole changes how AZD5335 moves through the body over time in adults with o… Recruiting

2025-522731-34-00 Ovarian cancer Primary peritoneal cancer Fallopian tube 2026-01-23
A Study in Adults with Parkinson's Disease and a Lack of Interest or Motivation to Test How Different Doses of IRL757 Given for Multiple Day… Recruiting

2025-523612-37-00 Parkinson's Disease and Apathy 2026-01-23
Pharmacokinetics, pharmacodynamics, safety, and tolerability of an acetonic milk thistle extract, standardized to silymarin, in subjects wit… Recruiting

2025-522423-95-00 chronic liver disease 2026-01-14
A phase I, prospective, mono-center, double-blinded, randomized, controlled study to assess the safety and tolerability of intraarticular in… Recruiting

2024-517421-12-00 Osteoarthritis 2026-01-07
Pilot Study on Subcutaneously Administered Immunotherapy for the Treatment of Cervical Cancer Recruiting

2025-521771-31-00 Cervical Cancer 2026-01-05
A trial to investigate the safety and pharmacokinetics of GRT6019 in healthy male participants. Recruiting

2025-523587-20-00 Not applicable for phase I study 2026-01-05
Dose Escalation Study with Bispecific Antibodies in Adult Patients with Lupus Nephritis Recruiting

2024-518288-37-00 Lupus Nephritis 2025-12-18
Phase I-Ib clinical trial of safety and immunobiology of prophylactic infusion of lymphocytes and NK cells after Allo-HCT. Recruiting

2024-517002-28-01 graft-versus-host disease 2025-12-17
NeoTISLEGA - A phase Ib trial evaluating the safety and activity of neoadjuvant combination of tislelizumab plus FLOT for resectable esophag… Recruiting

2024-519993-38-00 resectable esophagogastric adenocarcinoma 2025-12-12
Pharmacokinetics of NTRX-07 in fed and fasted participants Recruiting

2025-523695-23-00 Not applicable (trial is a pharmacokinetic study in hea 2025-12-11
A Phase 1b open label pilot study of CLN-978 for the treatment of moderate to severe systemic lupus erythematosus (SLE) Recruiting

2024-518780-36-00 Systemic Lupus Erythematosus 2025-12-10
A phase I Study to Assess the Safety and Tolerability of MBF-362 in Healthy Women, and Preliminary Efficacy in Otherwise Healthy Women diagn… Recruiting

2025-521809-40-00 Primary Dysmenorrhea 2025-12-10
A randomised, open-label, parallel group study to compare the pharmacokinetics and pharmacodynamics of NEODIDRO® 0.266 mg vs DIBASE® 25,000 … Recruiting

2024-516252-17-00 Patients with low Vitamin D plasma level 2025-12-09
ProspectivE phase 0 pilot study, assessing potential prognostic and theranostic interest of 68Ga-PentiXafor PET-CT In metastatic triple neGa… Recruiting

2024-517658-90-00 triple-negative breast cancer 2025-12-01
A study to find how well budoprutug (TNT119) works and how safe it is in participants with Systemic Lupus Erythematosus Recruiting

2024-520385-57-01 Systemic Lupus Erythematosus 2025-11-26
Subcutaneous Trastuzumab Deruxtecan Phase 1 Trial. Recruiting

2024-516625-31-00 Advanced Solid Tumor 2025-11-25
A study to test whether treatment with BI 770371 in combination with pembrolizumab with or without cetuximab helps people with head and neck… Recruiting

2024-517091-38-00 Head and neck squamous cell carcinoma 2025-11-25